These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 23322510

  • 1. What affects the quality of life in autoimmune Addison's disease?
    Meyer G, Hackemann A, Penna-Martinez M, Badenhoop K.
    Horm Metab Res; 2013 Feb; 45(2):92-5. PubMed ID: 23322510
    [Abstract] [Full Text] [Related]

  • 2. Sexuality and fertility in women with Addison's disease.
    Erichsen MM, Husebye ES, Michelsen TM, Dahl AA, Løvås K.
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4354-60. PubMed ID: 20610594
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of coeliac disease in Italian patients affected by Addison's disease.
    Biagi F, Campanella J, Soriani A, Vailati A, Corazza GR.
    Scand J Gastroenterol; 2006 Mar; 41(3):302-5. PubMed ID: 16497617
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Health-related quality of life in primary and secondary adrenal insufficiency.
    Aulinas A, Webb SM.
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):873-88. PubMed ID: 25252879
    [Abstract] [Full Text] [Related]

  • 7. Does recovery of adrenal function occur in patients with autoimmune Addison's disease?
    Smans LC, Zelissen PM.
    Clin Endocrinol (Oxf); 2011 Apr; 74(4):434-7. PubMed ID: 21114513
    [Abstract] [Full Text] [Related]

  • 8. Impaired health-related quality of life in Addison's disease--impact of replacement therapy, comorbidities and socio-economic factors.
    Kluger N, Matikainen N, Sintonen H, Ranki A, Roine RP, Schalin-Jäntti C.
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):511-8. PubMed ID: 24801591
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral density is reduced in female but not male subjects with Addison's disease.
    Florkowski CM, Holmes SJ, Elliot JR, Donald RA, Espiner EA.
    N Z Med J; 1994 Feb 23; 107(972):52-3. PubMed ID: 8115069
    [Abstract] [Full Text] [Related]

  • 10. Subjective health status in Norwegian patients with Addison's disease.
    Løvås K, Loge JH, Husebye ES.
    Clin Endocrinol (Oxf); 2002 May 23; 56(5):581-8. PubMed ID: 12030907
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M, Gryczyńska M, Sowińska A, Sowiński J.
    Przegl Lek; 2011 May 23; 68(2):96-102. PubMed ID: 21751518
    [Abstract] [Full Text] [Related]

  • 13. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death.
    Erichsen MM, Løvås K, Fougner KJ, Svartberg J, Hauge ER, Bollerslev J, Berg JP, Mella B, Husebye ES.
    Eur J Endocrinol; 2009 Feb 23; 160(2):233-7. PubMed ID: 19011006
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA expressions in PMBCs, CD4+, and CD8+ T-cells from patients suffering from autoimmune Addison's disease.
    Bernecker C, Halim F, Haase M, Willenberg HS, Ehlers M, Schott M.
    Horm Metab Res; 2013 Aug 23; 45(8):599-604. PubMed ID: 23589231
    [Abstract] [Full Text] [Related]

  • 15. Clinical profile and prognosis of Addison's disease in India.
    Agarwal G, Bhatia E, Pandey R, Jain SK.
    Natl Med J India; 2001 Aug 23; 14(1):23-5. PubMed ID: 11242694
    [Abstract] [Full Text] [Related]

  • 16. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
    Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES.
    Eur J Endocrinol; 2009 Jun 23; 160(6):993-1002. PubMed ID: 19282465
    [Abstract] [Full Text] [Related]

  • 17. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
    Petersen KS, Rushworth RL, Clifton PM, Torpy DJ.
    BMC Endocr Disord; 2015 Oct 24; 15():61. PubMed ID: 26500000
    [Abstract] [Full Text] [Related]

  • 18. Modified-release prednisone decreases complaints and fatigue compared to standard prednisolone in patients with adrenal insufficiency.
    Langenheim J, Ventz M, Hinz A, Quinkler M.
    Horm Metab Res; 2013 Feb 24; 45(2):96-101. PubMed ID: 22752958
    [Abstract] [Full Text] [Related]

  • 19. Quality of life in patients with Addison's disease: effects of different cortisol replacement modes.
    Riedel M, Wiese A, Schürmeyer TH, Brabant G.
    Exp Clin Endocrinol; 1993 Feb 24; 101(2):106-11. PubMed ID: 8405139
    [Abstract] [Full Text] [Related]

  • 20. Development of a disease-specific quality of life questionnaire in Addison's disease.
    Løvås K, Curran S, Oksnes M, Husebye ES, Huppert FA, Chatterjee VK.
    J Clin Endocrinol Metab; 2010 Feb 24; 95(2):545-51. PubMed ID: 20016050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.